Home
Conditions
Acinar Cell Adenocarcinoma of the Pancreas

Clinical trial condition

Acinar Cell Adenocarcinoma of the Pancreas

Explore clinical trials studying Acinar Cell Adenocarcinoma of the Pancreas. Study availability and eligibility vary by location and protocol.

16 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Acinar Cell Adenocarcinoma of the Pancreas trial results

Completed

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

NCT02047474

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Smilow Cancer Hospital at Fairfield Fairfield, Connecticut, United States

Smilow Cancer Hospital at Guilford Guilford, Connecticut, United States

Smilow Cancer Hospital at St. Francis Hospital Hartford, Connecticut, United States

Yale University New Haven, Connecticut, United States

View Trial Details

Completed

Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer

NCT01821612

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States

The James Graham Brown Cancer Center at University of Louisville Louisville, Kentucky, United States

View all 14 locations

View Trial Details

Completed

Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer

NCT02178436

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

Stony Brook University Cancer Center Stony Brook, New York, United States

View Trial Details

Completed

CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer

NCT01835041

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride

NCT00981162

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: University of Colorado at Denver Health Sciences Center Aurora, Colorado, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer

NCT01924260

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: UC Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Completed

Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer

NCT01666730

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer

NCT00031694

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Montefiore Medical Center The Bronx, New York, United States

View Trial Details

Completed

Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer

NCT02153450

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

NCT01643499

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of Unknown Primary, Adenocarcinoma of the Gallbladder, +67 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

Evanston CCOP-NorthShore University HealthSystem Evanston, Illinois, United States

View Trial Details

Acinar Cell Adenocarcinoma of the Pancreas

Acinar Cell Adenocarcinoma of the Pancreas trial results

Related conditions